Inicio › Cáncer de pulmón › Georgia

Ensayos clínicos de Cáncer de pulmón en Georgia

40 estudios sobre Cáncer de pulmón buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Piedmont Healthcare, Atlanta
John B Amos Cancer Center, Columbus

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Northside Hospital, Atlanta
Northside Hospital - Duluth, Duluth
Northeast Georgia Medical Center-Gainesville, Gainesville
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

CTCA at Southeastern Regional Medical Center, Newnan

ReclutandoFase 3

Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Phoebe Putney Memorial Hospital ( Site 4016), Albany
Piedmont Atlanta Hospital ( Site 4000), Atlanta
Emory University School of Medicine-Phase I ( Site 0056), Atlanta
y 4 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06312137

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Piedmont Cancer Institute, PC, Atlanta
City of Hope® Atlanta, Newnan
Summit Cancer Care PC, Savannah

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Northeast Georgia Medical Center Braselton, Braselton
Atlanta VA Medical Center, Decatur
Northeast Georgia Medical Center-Gainesville, Gainesville
y 4 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Emory University, Atlanta

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Emory University - Winship Cancer Institute, Atlanta

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07492680

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University Cancer & Blood Center, LLC, Athens
Emory University School of Medicine- Grady Campus, Atlanta
Winship Cancer Institute, Emory University, Atlanta

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Northwest Georgia Oncology Centers, P.C., Marietta

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06287775

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

University Cancer & Blood Center, Athens

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 oct 2026 · NCT05168566

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Emory University - Winship Cancer Institute, Atlanta

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 oct 2026 · NCT06582017

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

City of Hope Atlanta Cancer Center, Newnan

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT07288034

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Atlanta

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Northside Hospital Atlanta, Atlanta

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

Northeast Georgia Medical Center-Gainesville, Gainesville

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07393555

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Georgia Cancer Center at Augusta University, Augusta

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

City of Hope - Atlanta, Newnan

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07128199

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University Cancer and Blood Center LLC, Athens
Northeast Georgia Medical Center-Gainesville, Gainesville

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Grady Health System, Atlanta
Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
y 9 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

University Cancer & Blood Center, LLC, Athens

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07489066

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Winship Cancer Institute of Emory University, Atlanta

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)

Emory at Avalon - Primary Care, Alpharetta
Emory Clinic at Old Fourth Ward, Atlanta
Emory Clinic at Midtown, Atlanta
y 41 más

Reclutando

Edades de 50 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07711691

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Grady Health System, Atlanta
Emory Proton Therapy Center, Atlanta
Emory University Hospital Midtown, Atlanta
y 8 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Atlanta

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT05433142

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University Cancer and Blood Center LLC, Athens
Northside Hospital, Atlanta
Northside Hospital - Duluth, Duluth
y 3 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

University Cancer and Blood Center, Athens

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 27 may 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Piedmont Healthcare, Atlanta

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 may 2026 · NCT05379985

Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta
Emory Saint Joseph's Hospital, Atlanta

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 abr 2026 · NCT06495125

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Emory University Hospital/Winship Cancer Institute, Atlanta

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 31 mar 2026 · NCT04762199

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

City of Hope at Georgia - Atlanta, Newnan

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 mar 2026 · NCT06196008

Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer

Emory University/Winship Cancer Institute, Atlanta

ReclutandoFase 1 temprana

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 feb 2026 · NCT05493566

Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

Emory University Hospital Midtown, Atlanta
Emory University Hospital/Winship Cancer Institute, Atlanta

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 feb 2026 · NCT06731270

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Northside Hospital, Atlanta
Northeast Georgia Medical Center Braselton, Braselton
John B Amos Cancer Center, Columbus
y 8 más

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 ene 2026 · NCT06073431

Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer

Emory University Hospital Midtown, Atlanta
Emory University, Atlanta
Emory Saint Joseph's Hospital, Atlanta

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 31 oct 2025 · NCT05244239

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Atlanta
Massive Bio SYNERGY-AI site, Savannah

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

SpeciCare, Inc, Gainesville

ReclutandoEstudio observacional

Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.